Current issues in the design and interpretation of clinical trials.
Author:
- S J PocockSPS J Pocock
Abstract
Though there have been considerable improvements in the use of statistical methods for clinical trials in recent years, there remain major practical difficulties in the design and interpretation of many trials. This paper concentrates on problems relating to randomisation, the overemphasis on significance testing, and the inadequate size of many trials. Each topic is illustrated by examples from recent trials.Keywords
This publication has 11 references indexed in Scilit:
- Medical Research Council Vitamin Study.1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors.Journal of Clinical Oncology, 1983
- EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASEThe Lancet, 1981
- VITAMIN SUPPLEMENTATION AND NEURAL TUBE DEFECTSThe Lancet, 1981
- D-PENICILLAMINE TREATMENT IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSISThe Lancet, 1981
- POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATIONThe Lancet, 1980
- Restricted Randomization Designs in Clinical TrialsBiometrics, 1979
- Allocation of patients to treatment groups in a controlled clinical studyBritish Journal of Cancer, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976